Publication
A scalable insect cell-based production process of the human recombinant BMX for in-vitro covalent ligand high-throughput screening
| dc.contributor.author | Sousa, Bárbara B. | |
| dc.contributor.author | Sousa, Marcos F. Q. | |
| dc.contributor.author | Marques, Marta C. | |
| dc.contributor.author | Seixas, João D. | |
| dc.contributor.author | Brito, José A. | |
| dc.contributor.author | Matias, Pedro M. | |
| dc.contributor.author | Bernardes, Gonçalo J. L. | |
| dc.contributor.author | Roldão, António | |
| dc.date.accessioned | 2021-12-02T14:27:19Z | |
| dc.date.available | 2021-12-02T14:27:19Z | |
| dc.date.issued | 2020 | |
| dc.description | © Springer-Verlag GmbH Germany, part of Springer Nature 2020 | pt_PT |
| dc.description.abstract | Bone Marrow Tyrosine kinase in the chromosome X (BMX) is a TEC family kinase associated with numerous pathological pathways in cancer cells. Covalent inhibition of BMX activity holds promise as a therapeutic approach against cancer. To screen for potent and selective covalent BMX inhibitors, large quantities of highly pure BMX are normally required which is challenging with the currently available production and purification processes. Here, we developed a scalable production process for the human recombinant BMX (hrBMX) using the insect cell-baculovirus expression vector system. Comparable expression levels were obtained in small-scale shake flasks (13 mL) and in stirred-tank bioreactors (STB, 5 L). A two-step chromatographic-based process was implemented, reducing purification times by 75% when compared to traditional processes, while maintaining hrBMX stability. The final production yield was 24 mg of purified hrBMX per litter of cell culture, with a purity of > 99%. Product quality was assessed and confirmed through a series of biochemical and biophysical assays, including circular dichroism and dynamic light scattering. Overall, the platform herein developed was capable of generating 100 mg purified hrBMX from 5 L STB in just 34 days, thus having the potential to assist in-vitro covalent ligand high-throughput screening for BMX activity inhibition. | pt_PT |
| dc.description.sponsorship | This work has received funding from the European Union Horizon 2020 research and innovation program, under grant agreement No 702428. Royal Society to G.J.L.B. (URF\R\180019), FCT Portugal (iFCT to G.J.L.B., IF/00624/2015, Postdoctoral Fellowship SFRH/BPD/95253/2013 to J.D.S., and PTDC/MED-QUI/28764/2017 to J.D.S.), Marie Sklodowska-Curie IF (grant agreement No. 702428 to J.D.S. Investigador FCT programme 2014 (IF/01704/2014 and IF/01704/2014/CP1229/CT0001) to A.R. and from iNOVA4 Health Research Unit (LISBOA-01-0145-FEDER-007344) FCT/ Ministério da Educação e Ciência, FCT/MCTES, FEDER, and Programa Operacional Competitividade e Internacionalização (POCI) are also acknowledged. FCT SFRH/BPD/118731/2016 to M.C.M. FCT SFRH/BD/143583/2019 to B.B.S. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Bioprocess Biosyst Eng. 2021 Jan;44(1):209-215 | pt_PT |
| dc.identifier.doi | 10.1007/s00449-020-02421-6 | pt_PT |
| dc.identifier.eissn | 1615-7605 | |
| dc.identifier.issn | 1615-7591 | |
| dc.identifier.uri | http://hdl.handle.net/10451/50243 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Springer Nature | pt_PT |
| dc.relation | IF/00624/2015 | pt_PT |
| dc.relation | A Small Molecule Drug Conjugate SMDC for Prostate Cancer Therapy | |
| dc.relation | IF/01704/2014 | pt_PT |
| dc.relation | Next Generation Seasonal Influenza Vaccines: Towards a VLP-based Production Platform | |
| dc.relation | Engineering fusion inhibitor peptides against childhood respiratory viruses | |
| dc.relation | Combinatorial Antibody Synthesis for the discovery of Targeted Immunomodulators | |
| dc.relation.publisherversion | https://www.springer.com/journal/449 | pt_PT |
| dc.subject | Bioprocess development | pt_PT |
| dc.subject | Cancer therapy | pt_PT |
| dc.subject | IC-BEVS | pt_PT |
| dc.subject | hrBMX crystallization | pt_PT |
| dc.subject | hrBMX production | pt_PT |
| dc.title | A scalable insect cell-based production process of the human recombinant BMX for in-vitro covalent ligand high-throughput screening | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | A Small Molecule Drug Conjugate SMDC for Prostate Cancer Therapy | |
| oaire.awardTitle | Next Generation Seasonal Influenza Vaccines: Towards a VLP-based Production Platform | |
| oaire.awardTitle | Engineering fusion inhibitor peptides against childhood respiratory viruses | |
| oaire.awardTitle | Combinatorial Antibody Synthesis for the discovery of Targeted Immunomodulators | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBPD%2F95253%2F2013/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FMED-QUI%2F28764%2F2017/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/Investigador FCT/IF%2F01704%2F2014%2FCP1229%2FCT0001/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBPD%2F118731%2F2016/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/OE/SFRH%2FBD%2F143583%2F2019/PT | |
| oaire.citation.endPage | 215 | pt_PT |
| oaire.citation.issue | 1 | pt_PT |
| oaire.citation.startPage | 209 | pt_PT |
| oaire.citation.title | Bioprocess and Biosystems Engineering | pt_PT |
| oaire.citation.volume | 44 | pt_PT |
| oaire.fundingStream | 3599-PPCDT | |
| oaire.fundingStream | Investigador FCT | |
| oaire.fundingStream | OE | |
| person.familyName | C. Marques | |
| person.familyName | Bernardes | |
| person.givenName | Marta | |
| person.givenName | Gonçalo | |
| person.identifier.ciencia-id | 3A1D-10AB-43BC | |
| person.identifier.orcid | 0000-0002-5093-5918 | |
| person.identifier.orcid | 0000-0001-6594-8917 | |
| person.identifier.rid | A-5725-2019 | |
| person.identifier.scopus-author-id | 35085375600 | |
| person.identifier.scopus-author-id | 14046757500 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 292027d7-0dbf-4463-bb29-73a6905a2fe7 | |
| relation.isAuthorOfPublication | d1a48067-77b1-4413-b1c7-602fb18c62c0 | |
| relation.isAuthorOfPublication.latestForDiscovery | 292027d7-0dbf-4463-bb29-73a6905a2fe7 | |
| relation.isProjectOfPublication | 6fa677fe-2900-40bd-80cc-a5390e3d8384 | |
| relation.isProjectOfPublication | 35ef0556-1a06-429e-8efb-a46e97818819 | |
| relation.isProjectOfPublication | 0d622055-c032-4957-869d-f9054f92aad7 | |
| relation.isProjectOfPublication | b0f9ccf2-7df8-43c2-8c3c-46b503c90ed2 | |
| relation.isProjectOfPublication | dfa24b80-30de-4a55-8b98-36be56813e9c | |
| relation.isProjectOfPublication.latestForDiscovery | 6fa677fe-2900-40bd-80cc-a5390e3d8384 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Scalable_insect.pdf
- Size:
- 1.66 MB
- Format:
- Adobe Portable Document Format
